SD-169 (Standard)
SD-169 is an orally active ATP-competitive inhibitor of p38α MAPK, with an IC50 of 3.2 nM. SD-169 also weakly inhibits p38β MAPK with an IC50 of 122 nM. SD-169 prevents the development and progression of diabetes by inhibiting T cell infiltration and activation[1].
Product Specifications
CAS Number
[1670-87-7]
UNSPSC
12352005
Target
P38 MAPK
Related Pathways
MAPK/ERK Pathway
Field of Research
Metabolic Disease
Smiles
O=C(C1=CC2=C(NC=C2)C=C1)N
Molecular Formula
C9H8N2O
Molecular Weight
160.18
References & Citations
[1]Medicherla S, et al. Preventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetes. J Pharmacol Exp Ther. 2006 Jul;318 (1) :99-107.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
More Discoveries
Explore Other Products
Browse additional items from our catalog
JOT-EK7103Hu 96 wells
Human Retinoid-inducible serine carboxypeptidase,SCPEP1 ELISA KIT
Sign In for Pricing
View Details 